An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain
Authors:
- Wayne A. SchreierWSWayne A. Schreier
- David G. MorganDMDavid G. Morgan
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptideBrain Research, 1993
- Synthetic amyloid β-protein fails to produce specific neurotoxicity in monkey cerebral cortexNeurobiology of Aging, 1992
- Intracerebral /sB-amyloid(25–35) produces tissue damage: Is it neurotoxic?Neurobiology of Aging, 1992
- Implants containing β-amyloid protein are not neurotoxic to young and old rat brainNeurobiology of Aging, 1992
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991
- Astrocyte hypertrophy in the Alzheimer's disease hippocampal formationExperimental Neurology, 1991
- Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.Journal of Cell Biology, 1990
- Complement activation in amyloid plaques in Alzheimer’s dementiaVirchows Archiv B Cell Pathology Including Molecular Pathology, 1988
- Synthesis and release of chondroitin sulphate and heparan sulphate proteoglycans from mouse macrophagesin vitroGlycoconjugate Journal, 1987
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984